Fundamentals

Radiopharm Theranostics Ltd

RADX

Soon

Sentiment

Soon

Options

Revenue

3.63M

▲3.63M∞%

-

Assets

86.48M

▲14.45M▲20.05%

12 Months Change

Liabilities

43.61M

▼-1.07M▼-2.40%

12 Months Change

Free Cash Flow

-23.25M

▼-23.25M-∞%

-

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001213900-25-088699